1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
625C7E372D5BEB52765258252002A95C0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/25C7E372D5BEB52765258252002A95C0!OpenDocument
18
19OpenDocument
2034.239.154.240
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Communications » External Communication Excellence

Document Excerpt: Identifying Superior Corporate Affairs / Corporate Communications Capabilities

DB Image

ID: MD-598


Features:

3 Info Graphics

18 Data Graphics

530+ Metrics

5 Narratives


Pages/Slides: 4


Published: 2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5498 "Identifying Superior Corporate Affairs / Corporate Communications Capabilities".

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Amgen; Bayer; GlaxoSmithKline ; Johnson & Johnson; Lilly; Lundbeck; Merck; Novartis; Novozymes; Otsuka; Sanofi; Shire; Spark Therapeutics; Takeda Pharmaceuticals; Tesaro; Teva; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.